The lipolysis inhibitor acipimox reverses the cardiac phenotype induced by electronic cigarettes.

Espinoza-Derout J, Arambulo JML, Ramirez-Trillo W, Rivera JC, Hasan KM, Lao CJ, Jordan MC, Shao XM, Roos KP, Sinha-Hikim AP, Friedman TC. The lipolysis inhibitor acipimox reverses the cardiac phenotype induced by electronic cigarettes. Sci Rep. 2023 10 25; 13(1):18239.

View in: PubMed

subject areas

Animals
Cytokines
Humans
Lipolysis
Mice
Mice, Inbred C57BL
Nicotine
Phenotype

authors with profiles

Xuesi Max Shao, MD
Amiya P Sinha-Hikim, PhD
Jorge A. Espinoza-Derout, PhD
Kamrul M Hasan, PhD
Theodore C. Friedman, MD, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support